WHO ICTRP trial
Investigation of the effects of synbiotics…
JPRN-UMIN000032057 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000032057 |
|---|---|
| Public title | Investigation of the effects of synbiotics (Lactobacillus,Bifidobacterium/oligosaccharide) on chronic inflammation in type 2 diabetes mellitus |
| Scientific title | Investigation of the effects of synbiotics (Lactobacillus,Bifidobacterium/oligosaccharide) on chronic inflammation in type 2 diabetes mellitus - The effects of synbiotics in type 2 diabetes mellitus |
| Primary sponsor | Juntendo University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | type 2 diabetes mellitus |
| Interventions | The intervention group takes Supersynbiotics LBG-P(Lactobacillus,Bifidobacterium 3.0g/day and oligosaccharide 20.4g/day) for 24 weeks. The control group continues current therapy and takes no synbiotics. |
| Registration date | Feb 4, 2018 |
| Target size | 88 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: